Literature DB >> 25479116

The epidemiology of vasospasm in children with moderate-to-severe traumatic brain injury.

Nicole F O'Brien1, Tensing Maa, Keith O Yeates.   

Abstract

OBJECTIVE: To gain a description of the prevalence and time course of vasospasm in children suffering moderate-to-severe traumatic brain injury.
DESIGN: A prospective, observational study was performed. Children with a diagnosis of traumatic brain injury, a Glasgow Coma Score less than or equal to 12, and abnormal head imaging were enrolled. Transcranial Doppler ultrasound was performed to identify and follow vasospasm. Diagnostic criteria included flow velocity elevation more than or equal to 2 sd above age and gender normal values for the middle cerebral and basilar arteries. Additional criteria required for vasospasm diagnosis in the middle cerebral artery was a ratio of flow in the middle cerebral artery to extracranial internal carotid artery more than or equal to 3.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Sixty-nine children were included. The prevalence of middle cerebral artery vasospasm in children with moderate traumatic brain injury (Glasgow Coma Score, 9-12) was 8.5% and was 33.5% in those with severe traumatic brain injury (Glasgow Coma Score, ≤ 8). The prevalence of basilar artery vasospasm in children with moderate traumatic brain injury was 3% and with severe traumatic brain injury was 21%. Mean time to onset of vasospasm was 4 days (± 2 d) in the middle cerebral arteries and 5 days (± 2.5 d) in the basilar artery. Mean duration of vasospasm in the middle cerebral artery was 2 days (± 2 d) and 1.5 days (± 1 d) in the basilar artery. Children in whom vasospasm developed were more likely to have been involved in motor vehicle accidents, had higher Injury Severity Scores, had fever at admission, and had lower Glasgow Coma Score scores. Good neurologic outcome (Glasgow Outcome Score Extended Pediatric version of ≥ 4) at 1 month from injury was seen in 76% of those with moderate traumatic brain injury without vasospasm and in 40% of those with vasospasm. In those with severe traumatic brain injury, good neurologic outcome was seen in 29% of those children without vasospasm and in 15% of those with vasospasm.
CONCLUSIONS: Vasospasm occurs in a sizeable number of children with moderate and severe traumatic brain injury. Children in whom vasospasm developed were more likely to have been involved in a motor vehicle accident, had higher Injury Severity Scores, had fever at admission, and had lower Glasgow Coma scores than in those whom vasospasm did not develop. Based on these findings, we recommend aggressive screening for posttraumatic vasospasm in these patients. Future studies should establish the relationship between vasospasm and long-term functional outcomes and should also evaluate potential preventative or therapeutic options for vasospasm in these children.

Entities:  

Mesh:

Year:  2015        PMID: 25479116     DOI: 10.1097/CCM.0000000000000745

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  12 in total

1.  Presenting Characteristics Associated With Outcome in Children With Severe Traumatic Brain Injury: A Secondary Analysis From a Randomized, Controlled Trial of Therapeutic Hypothermia.

Authors:  Bedda L Rosario; Christopher M Horvat; Stephen R Wisniewski; Michael J Bell; Ashok Panigrahy; Giulio Zuccoli; Srikala Narayanan; Goundappa K Balasubramani; Sue R Beers; P David Adelson
Journal:  Pediatr Crit Care Med       Date:  2018-10       Impact factor: 3.624

2.  Transcranial Doppler Ultrasound Use in Pediatric Traumatic Brain Injury.

Authors:  Karin Reuter-Rice
Journal:  J Radiol Nurs       Date:  2017-02-16

3.  Relationships between cerebral flow velocities and neurodevelopmental outcomes in children with moderate to severe traumatic brain injury.

Authors:  Nicole Fortier O'Brien; Tensing Maa; Melissa Moore-Clingenpeel; Nathan Rosenberg; Keith Owen Yeates
Journal:  Childs Nerv Syst       Date:  2017-12-20       Impact factor: 1.475

4.  Reference values for cerebral blood flow velocities in critically ill, sedated children.

Authors:  Nicole Fortier O'Brien
Journal:  Childs Nerv Syst       Date:  2015-08-19       Impact factor: 1.475

Review 5.  Anatomical and Physiological Differences between Children and Adults Relevant to Traumatic Brain Injury and the Implications for Clinical Assessment and Care.

Authors:  Anthony A Figaji
Journal:  Front Neurol       Date:  2017-12-14       Impact factor: 4.003

Review 6.  Approaches to Multimodality Monitoring in Pediatric Traumatic Brain Injury.

Authors:  Brian Appavu; Brian T Burrows; Stephen Foldes; P David Adelson
Journal:  Front Neurol       Date:  2019-11-26       Impact factor: 4.003

7.  Predictors of Acute Vertebrobasilar Vasospasm following Tumor Resection in the Foramen Magnum Region.

Authors:  Chuanyuan Tao; Jiajing Wang; Yuekang Zhang; Shirong Qi; Fan Liu; Chao You
Journal:  PLoS One       Date:  2016-09-28       Impact factor: 3.240

8.  The TRPC6 inhibitor, larixyl acetate, is effective in protecting against traumatic brain injury-induced systemic endothelial dysfunction.

Authors:  Xingjuan Chen; Natalie N Taylor-Nguyen; Ashley M Riley; B Paul Herring; Fletcher A White; Alexander G Obukhov
Journal:  J Neuroinflammation       Date:  2019-01-31       Impact factor: 8.322

9.  Transcranial Doppler ultrasound findings in children with moderate-to-severe traumatic brain injury following abusive head trauma.

Authors:  Marlina E Lovett; Tensing Maa; Melissa Moore-Clingenpeel; Nicole F O'Brien
Journal:  Childs Nerv Syst       Date:  2019-11-28       Impact factor: 1.475

10.  International evidence-based guidelines on Point of Care Ultrasound (POCUS) for critically ill neonates and children issued by the POCUS Working Group of the European Society of Paediatric and Neonatal Intensive Care (ESPNIC).

Authors:  Yogen Singh; Cecile Tissot; María V Fraga; Nadya Yousef; Rafael Gonzalez Cortes; Jorge Lopez; Joan Sanchez-de-Toledo; Joe Brierley; Juan Mayordomo Colunga; Dusan Raffaj; Eduardo Da Cruz; Philippe Durand; Peter Kenderessy; Hans-Joerg Lang; Akira Nishisaki; Martin C Kneyber; Pierre Tissieres; Thomas W Conlon; Daniele De Luca
Journal:  Crit Care       Date:  2020-02-24       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.